• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期转移性性腺外内胚窦(卵黄囊)瘤的成功治疗。

Successful treatment of metastatic extragonadal endodermal sinus (yolk sac) tumor in childhood.

作者信息

Thomas W J, Kelleher J F, Duval-Arnould B

出版信息

Cancer. 1981 Dec 1;48(11):2371-4. doi: 10.1002/1097-0142(19811201)48:11<2371::aid-cncr2820481106>3.0.co;2-#.

DOI:10.1002/1097-0142(19811201)48:11<2371::aid-cncr2820481106>3.0.co;2-#
PMID:6170420
Abstract

Two children with metastatic extragonadal endodermal sinus tumor who had failed VAC chemotherapy were treated with combination chemotherapy consisting of cis-platinum, vinblastine, doxorubicin HCl (Adriamycin) and bleomycin (cis-VAB). There was a complete response in both patients with one child remaining tumor-free 3 1/2 years after metastasis and 2 1/2 years after stopping therapy. The main toxic reactions encountered were associated with the use of cis-platinum, but these were manageable and resolved upon completion of therapy. Cis-VAB appears to be a safe and effective regimen for the treatment of metastatic endodermal sinus tumor. A study of the efficacy of cis-VAB in a larger group of children with endodermal sinus tumor of poor prognosis seems indicated.

摘要

两名患有转移性性腺外内胚窦瘤且VAC化疗失败的儿童接受了由顺铂、长春碱、盐酸阿霉素(阿霉素)和博来霉素组成的联合化疗(顺铂-VAB)。两名患者均出现完全缓解,其中一名儿童在转移后3.5年及停止治疗后2.5年仍无肿瘤。主要的毒副反应与顺铂的使用有关,但这些反应是可控的,治疗结束后得以缓解。顺铂-VAB似乎是治疗转移性内胚窦瘤的一种安全有效的方案。似乎有必要对顺铂-VAB在更大一组预后不良的内胚窦瘤儿童中的疗效进行研究。

相似文献

1
Successful treatment of metastatic extragonadal endodermal sinus (yolk sac) tumor in childhood.儿童期转移性性腺外内胚窦(卵黄囊)瘤的成功治疗。
Cancer. 1981 Dec 1;48(11):2371-4. doi: 10.1002/1097-0142(19811201)48:11<2371::aid-cncr2820481106>3.0.co;2-#.
2
Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor.
Obstet Gynecol. 1980 Sep;56(3):396-401.
3
Primary yolk sac (endodermal sinus) tumor of the prostate: case report and review of the literature.前列腺原发性卵黄囊瘤(内胚窦瘤):病例报告及文献复习
Prostate. 1990;17(2):137-43. doi: 10.1002/pros.2990170207.
4
Therapy of extragonadal germ-cell tumors.性腺外生殖细胞肿瘤的治疗
Eur J Cancer Clin Oncol. 1983 Jul;19(7):895-9. doi: 10.1016/0277-5379(83)90054-8.
5
Prolonged survival with conventional cisplatinum/vinblastine/bleomycin therapy alone for mediastinal endodermal sinus tumour.单纯采用传统的顺铂/长春花碱/博来霉素疗法对纵隔内胚窦瘤进行治疗可实现长期存活。
Aust N Z J Med. 1987 Jun;17(3):336-7. doi: 10.1111/j.1445-5994.1987.tb01240.x.
6
Successful treatment of mediastinal germ cell/endodermal sinus tumors.纵隔生殖细胞/内胚窦瘤的成功治疗。
Chest. 1985 Jul;88(1):64-9. doi: 10.1378/chest.88.1.64.
7
Anterior mediastinal endodermal sinus (yolk sac) tumor in a female infant.
Cancer. 1985 Sep 15;56(6):1430-3. doi: 10.1002/1097-0142(19850915)56:6<1430::aid-cncr2820560634>3.0.co;2-u.
8
Endodermal sinus tumor of the mediastinum. Report of apparent cure in two patients with extensive disease.纵隔内胚窦瘤。两名患有广泛性疾病的患者获明显治愈的报告。
Chest. 1984 Nov;86(5):745-7. doi: 10.1378/chest.86.5.745.
9
[Case of yolk sac tumor decreasing in size and the normalizing of alph-fetoprotein level by anticancer chemotherapy].[卵黄囊瘤经抗癌化疗后肿瘤缩小及甲胎蛋白水平恢复正常的病例]
Gan To Kagaku Ryoho. 1984 Feb;11(2):333-6.
10
[VAB-3 chemotherapy of endodermal sinus tumor of the ovary].[卵巢内胚窦瘤的VAB-3化疗]
Nihon Gan Chiryo Gakkai Shi. 1987 Feb 20;22(1):75-80.

引用本文的文献

1
Clinical characteristics and prognostic models of gonadal and extra-gonadal yolk sac tumors: a population-based analysis in children and adolescents.基于人群的儿童和青少年性腺和性腺外卵黄囊瘤的临床特征和预后模型分析。
World J Urol. 2023 Nov;41(11):3009-3017. doi: 10.1007/s00345-023-04616-4. Epub 2023 Sep 25.
2
Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83).
Cancer Chemother Pharmacol. 1989;24 Suppl 1:S34-9. doi: 10.1007/BF00253238.